In cisplatin-resistant bladder cancer cell lines, FLRT2, HOXC5, SCD, GRM7, HMGA1, ETV7, and SCO2 were highly expressed, while EMP1, SERPINA6, and ZNF124 exhibited lower expression levels (Figure 5B). This evidence concerns the gene SERPINA6 and urinary bladder cancer.